The Kable

The Kable

💊 J&J halts Covid-19 vaccine production, Pfizer predicts another bumper year, Deloitte expands, BioSplice contracts, #HKhamsters report from the ether

Vinod's avatar
Vinod
Feb 09, 2022
∙ Paid
Share

Thank god it’s Wednesday. Which means only two more days to the weekend. And thinking about vaccine inequity. Which is covered in today’s issue. Along with news from the anti-aging space. And approvals and investments in and from India. And Deloitte applying healthcare learning to consumer services.

Keep reading with a 7-day free trial

Subscribe to The Kable to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 The Kable
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture